Eli Lilly to buy Kelonia Therapeutics in up to $7 billion cancer immunotherapy drug deal

got some M&A news or we think out of Angelica Peoples at HQ. Morning Angelica Carl. That's right.We have another deal from Lily. That company is acquiring Colonia Therapeutics for up to 7 billion with $3.25% billion upfront. So Colonia is developing invivo carti therapies where you reprogram tea cells to attack cancer but inside the body.And right now carti's done xvivo. So you basically have this procedure that's a bone marrow transplant. And I just got off the phone with Lily's head of oncology and busine ...